What women should know about fibroids

Uterine fibroids are non-cancerous growths that develop in the uterus, affecting a significant number of women during their reproductive years. Understanding the nature of fibroids, including their symptoms, causes, diagnostic methods, and treatment options, is crucial for managing this common condition effectively. This article provides an in-depth look at uterine fibroids and how they can impact women’s health.

What are Uterine Fibroids?

Uterine fibroids, also known as leiomyomas or myomas, are benign tumors that arise from the muscle tissue of the uterus. While these growths are non-cancerous, they can vary in size and number, leading to a range of symptoms that can affect a woman’s quality of life. Fibroids can be classified based on their location within the uterus:

  • Submucosal Fibroids: These grow just beneath the lining of the uterus and can protrude into the uterine cavity.
  • Intramural Fibroids: Found within the muscular wall of the uterus, these are the most common type.
  • Subserosal Fibroids: These develop on the outer surface of the uterus and can extend outward.

Symptoms of Uterine Fibroids

The symptoms of uterine fibroids can vary widely among women. While some women may remain asymptomatic, others can experience significant discomfort and complications. Common symptoms include:

  • Heavy or Prolonged Menstrual Periods: Many women with fibroids experience menorrhagia, which can lead to anemia.
  • Pelvic Pain and Pressure: Large fibroids can cause a feeling of heaviness or pressure in the lower abdomen.
  • Pain During Sexual Intercourse: Fibroids, especially those near the cervix, can cause dyspareunia (painful intercourse).
  • Frequent Urination: Fibroids pressing against the bladder can lead to urinary frequency.
  • Lower Back Pain: This occurs when fibroids press against the muscles and nerves of the lower back.

These symptoms can severely impact daily life, making it essential for women to seek medical evaluation if they experience any of these issues.

Causes and Risk Factors

The exact cause of fibroids remains unclear, but several factors are believed to contribute to their development:

  • Hormonal Imbalances: Estrogen and progesterone, hormones that regulate the menstrual cycle, are known to promote the growth of fibroids .
  • Genetic Factors: Women with a family history of fibroids are more likely to develop them, indicating a genetic predisposition .
  • Age: Fibroids are most common in women in their 30s and 40s, and they typically shrink after menopause .
  • Obesity: Being overweight increases the risk of fibroids due to higher levels of estrogen produced by adipose (fat) tissue .
  • Race: African American women are more likely to develop fibroids and to experience severe symptoms than women of other racial backgrounds .

Diagnosis

Fibroids are often discovered during routine gynecological exams. When fibroids are suspected, imaging tests are typically used to confirm the diagnosis and assess the size and location of the fibroids:

  • Ultrasound: This is the most common imaging test for diagnosing fibroids and involves the use of sound waves to create a picture of the uterus.
  • Magnetic Resonance Imaging (MRI): MRI provides detailed images of the uterus and is particularly useful in mapping the size and location of fibroids before treatment .
  • Hysteroscopy: This procedure involves inserting a small camera through the cervix to examine the inside of the uterus, which is especially useful for detecting submucosal fibroids .

Treatment Options

While there is no definitive cure for fibroids, several treatments can help manage symptoms and improve quality of life. The choice of treatment depends on the severity of symptoms, the size and location of the fibroids, the patient’s age, and her desire to maintain fertility.

  • Medications: Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used to relieve pain, while hormonal treatments such as birth control pills, GnRH agonists, and progestins can help regulate menstrual cycles and reduce bleeding .
  • Minimally Invasive Procedures:
    • Uterine Artery Embolization (UAE): This procedure cuts off blood supply to the fibroid, causing it to shrink.
    • Magnetic Resonance-guided Focused Ultrasound (MRgFUS): This non-invasive procedure uses focused ultrasound waves to destroy fibroid tissue .
  • Surgical Options:
    • Myomectomy: This surgery involves the removal of fibroids while preserving the uterus, making it an option for women who wish to maintain fertility.
    • Hysterectomy: The complete removal of the uterus is considered the definitive treatment for fibroids and is usually recommended for women who do not wish to become pregnant .

Fibroids and Fertility

Fibroids can impact fertility and pregnancy in several ways. Submucosal fibroids, for instance, can interfere with implantation, while large fibroids may distort the shape of the uterus or block the fallopian tubes. Women with fibroids who are trying to conceive should consult with their healthcare provider to discuss treatment options that can preserve fertility .

Conclusion

Uterine fibroids are a common and often challenging condition for women of reproductive age. Being informed about the symptoms, causes, and available treatments is essential for managing fibroids effectively. Regular medical check-ups and imaging tests can help monitor fibroids and guide treatment decisions. Women should work closely with their healthcare providers to tailor a treatment plan that best suits their needs and lifestyle, especially if they are considering pregnancy.

References

  1. Parker, W. H. (2007). Uterine myomas: Management. Fertility and Sterility, 88(4), 1084-1086.
  2. Baird, D. D., Dunson, D. B., Hill, M. C., Cousins, D., & Schectman, J. M. (2003). High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence. American Journal of Obstetrics and Gynecology, 188(1), 100-107.
  3. Stewart, E. A. (2001). Uterine fibroids. The Lancet, 357(9252), 293-298.
  4. Cramer, S. F., & Patel, A. (1990). The frequency of uterine leiomyomas. American Journal of Clinical Pathology, 94(4), 435-438.
  5. Wise, L. A., Palmer, J. R., Harlow, B. L., Spiegelman, D., & Adams-Campbell, L. L. (2004). Risk of uterine leiomyomata in relation to tobacco, alcohol, and caffeine consumption in the Black Women’s Health Study. Human Reproduction, 19(8), 1746-1754.
  6. Al-Hendy, A., & Myers, E. R. (2021). Uterine fibroids: Burden and unmet medical need. Seminars in Reproductive Medicine, 39(3-4), 164-172.
  7. Dueholm, M. (2017). Uterine adenomyosis and infertility, review of reproductive outcomes after surgery. Acta Obstetricia et Gynecologica Scandinavica, 96(6), 715-726.
  8. Rein, M. S., Friedman, A. J., Barbieri, R. L., & Pavelka, K. (1990). Glycoprotein hormones in women with uterine leiomyomas. Fertility and Sterility, 54(1), 59-63.
  9. Bradley, L. D. (2006). Uterine fibroid embolization: A review of current outcomes. AJR. American Journal of Roentgenology, 186(5), 1242-1248.
  10. Hindley, J., Gedroyc, W. M., Regan, L., Stewart, E., Tempany, C., Hynnen, K., & McDannold, N. (2004). MRI guidance of focused ultrasound therapy of uterine fibroids: Early results. AJR. American Journal of Roentgenology, 183(6), 1713-1719.
  11. Donnez, J., & Dolmans, M. M. (2016). Uterine fibroid management: From the present to the future. Human Reproduction Update, 22(6), 665-686.
  12. Pritts, E. A. (2001). Fibroids and infertility: A systematic review of the evidence. Obstetrical & Gynecological Survey, 56(8), 483-491.